Cannabis Sativa

ATC code R02 Throat preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup R02 is part of the anatomical group R Respiratory system.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QR02.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

R02A Throat preparations[edit]

R02AA Antiseptics[edit]

R02AA01 Ambazone
R02AA02 Dequalinium
R02AA03 Dichlorobenzyl alcohol
R02AA05 Chlorhexidine
R02AA06 Cetylpyridinium
R02AA09 Benzethonium
R02AA10 Myristyl-benzalkonium
R02AA11 Chlorquinaldol
R02AA12 Hexylresorcinol
R02AA13 Acriflavinium chloride
R02AA14 Oxyquinoline
R02AA15 Povidone-iodine
R02AA16 Benzalkonium
R02AA17 Cetrimonium
R02AA18 Hexamidine
R02AA19 Phenol
R02AA20 Various
R02AA21 Octenidine

R02AB Antibiotics[edit]

R02AB01 Neomycin
R02AB02 Tyrothricin
R02AB03 Fusafungine
R02AB04 Bacitracin
R02AB30 Gramicidin

R02AD Anesthetics, local[edit]

R02AD01 Benzocaine
R02AD02 Lidocaine
R02AD03 Cocaine
R02AD04 Dyclonine
R02AD05 Ambroxol

R02AX Other throat preparations[edit]

R02AX01 Flurbiprofen
R02AX02 Ibuprofen
R02AX03 Benzydamine

References[edit]

  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code R02". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QR02". WHO Collaborating Centre for Drug Statistics Methodology.

Leave a Reply